Protagenic Therapeutics Stock Soars 123.35% in Pre-Market Trading

On April 3, 2025, Protagenic Therapeutics, Inc. Common Stock surged by 123.35% in pre-market trading, marking a significant rise that has caught the attention of investors and analysts alike.

Protagenic Therapeutics, Inc. has experienced high volatility in recent trading sessions, with its stock price fluctuating significantly. The company's stock has been identified as a sell candidate since March 7, 2025, with a loss of 29.55%. On April 2, 2025, the stock price fell by 9.20%, closing at $0.227. The stock has shown a downward trend over the past 10 days, with a total decrease of 9.2%.

Technical analysis indicates that Protagenic Therapeutics, Inc. Common Stock holds sell signals from both short and long-term moving averages, suggesting a negative outlook. The stock is expected to fall by 50.65% over the next three months, with a 90% probability of holding a price between $0.0590 and $0.134 at the end of this period. The stock's high volatility and wide trading range make it a very high-risk investment.

Despite the negative technical signals, there has been positive market activity for Protagenic Therapeutics, Inc. after regular trading hours. On Wednesday, the stock saw a 171.0% increase to $0.61, and during Wednesday's after-market session, it moved upwards by 151.6% to $0.57. These significant gains have contributed to the overall positive sentiment surrounding the stock.